AstraZeneca has announced significant progress in the development of a new blood pressure therapy, achieving its primary endpoint in a Phase 3 clinical trial. This breakthrough...
AstraZeneca has announced promising results from a late-stage clinical trial that demonstrates the effectiveness of its cancer treatment, Tagrisso (osimertinib), when used in conjunction with pemetrexed...